These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. Sengar P, Juárez P, Verdugo-Meza A, Arellano DL, Jain A, Chauhan K, Hirata GA, Fournier PGJ. J Nanobiotechnology; 2018 Feb 27; 16(1):19. PubMed ID: 29482561 [Abstract] [Full Text] [Related]
3. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents. Mukai H, Wada Y, Watanabe Y. Ann Nucl Med; 2013 Aug 27; 27(7):625-39. PubMed ID: 23605059 [Abstract] [Full Text] [Related]
4. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer. Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J, Shuin T. Photodiagnosis Photodyn Ther; 2013 Dec 27; 10(4):399-409. PubMed ID: 24284092 [Abstract] [Full Text] [Related]
8. Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies. Kwitniewski M, Juzeniene A, Ma LW, Glosnicka R, Graczyk A, Moan J. J Photochem Photobiol B; 2009 Mar 03; 94(3):214-22. PubMed ID: 19136276 [Abstract] [Full Text] [Related]
20. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model. Bozzini G, Colin P, Betrouni N, Maurage CA, Leroy X, Simonin S, Martin-Schmitt C, Villers A, Mordon S. Photodiagnosis Photodyn Ther; 2013 Sep 03; 10(3):296-303. PubMed ID: 23993856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]